卡瑞利珠单抗联合阿帕替尼及化疗二线或以上治疗HER-2阴性晚期胃癌的临床疗效及安全性
唐琳, 相明月, 张建波, 王丽丽, 巩合义, 韩大力
Clinical efficacy and safety of camrelizumab combined with apatinib and chemotherapy as second-line or later therapy in the treatment of HER-2 negative advanced gastric cancer
Tang Lin, Xiang Mingyue, Zhang Jianbo, Wang Lili, Gong Heyi, Han Dali
国际肿瘤学杂志
.
2022, (5): 276
-281
.
DOI: 10.3760/cma.j.cn371439-20220111-00051
